Triple negative breast cancer - BCL2 in prognosis and prediction. Review.
about
Age-associated prognostic and predictive biomarkers in patients with breast cancer.BCL2 as a Subtype-Specific Prognostic Marker for Breast CancerPrognostic Influence of BCL2 on Molecular Subtypes of Breast CancerTriple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification.BCL2 Regulation According to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma.
P2860
Q33750880-DC31C326-3ECA-4238-88F1-8B5AD39C7B89Q37316599-FD63F996-2A8B-4282-95CE-4A1779B54C5CQ37735963-26CAFA88-090A-4B0F-B0AB-7F5EE27B1E90Q38647802-102F339A-5B7C-45F3-88C3-ABD78C086CBCQ38682221-82E9D837-E563-4BC1-88E7-74877294035FQ42471884-AE2757C8-6B8D-43A2-9283-A84549231E83Q55283405-77B7BFC0-2194-4A18-9718-DA224B294FB4
P2860
Triple negative breast cancer - BCL2 in prognosis and prediction. Review.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Triple negative breast cancer - BCL2 in prognosis and prediction. Review.
@en
type
label
Triple negative breast cancer - BCL2 in prognosis and prediction. Review.
@en
prefLabel
Triple negative breast cancer - BCL2 in prognosis and prediction. Review.
@en
P2093
P1433
P1476
Triple negative breast cancer - BCL2 in prognosis and prediction. Review.
@en
P2093
Alice Hlobilkova
Gvantsa Kharaishvili
Jan Bouchal
Jana Vrbkova
Katerina Bouchalova
Magdalena Megova
P304
P356
10.2174/1389450115666141106151143
P577
2014-01-01T00:00:00Z